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background:  Percutaneous mitral balloon valvuloplotomy (PMV) has been accepted as a safe and effective treatment for moderate and severe 
mitral stenosis (MS). However, the difference of long term outcomes between moderate and severe MS after PMV is not well-known. Thus, the 
purpose of this study was to compare the long term outcomes of PMV between moderate and severe MS.
methods:  A single institution retrospective study was performed for patients who underwent PMV from March 1988 to March 2012. Clinical and 
echocardiography parameters were compared between moderate (n=478) and severe (n=580) MS. Long term outcomes including redo-PMV, mitral 
valve replacement (MVR), stroke, death and composite of all outcomes were analyzed.
results:  Mean mitral valve area (MVA) before PMV was 0.80 ± 0.12 in severe MS and 1.15 ± 0.13 in moderate MS(p<0.001). Severe MS 
showed higher New York Heart Association score (2.70 ± 0.50 vs. 2.58 ± 0.55, p<0.001), echoscore (8.1 ± 1.3 vs. 7.7 ± 1.2, p<0.001) and mean 
diastolic pressure gradient (11.7 ± 6.6 vs. 8.5 ± 5.1, p=0.012) compared with moderate MS. After PMV, optimal result was obtained in 88.5%. 
Post-procedural MVA (1.70 ± 0.33 vs. 1.77 ± 0.29, p=0.001) were smaller but acute gain (120 ± 59% vs. 56 ± 28%, p<0.001)) was greater in 
severe MS than moderate MS. After a median follow up period of 147 months (interquartile: 48, 229), 56(5.36%) redo-PMV, 260 (24.6%) MVR, 26 
(2.5%) stroke and 29 (2.7%) death were occurred. Severe MS showed more MVR [158 (27.2%) vs. 102 (21.3%), p=0.026] and worse composite of 
all outcomes (p=0.016) in Kaplan-meier survival analysis. MVA before PMV (Hazard ratio (HR):0.43, p=0.002), Age (HR:1.01, p=0.048), Echoscore 
(HR:1.13, p=0.014) were the determinants of long term outcome.
conclusions:  Early PMV in moderate MS show better long term outcomes compared with PMV in severe MS.
